You are here: Industry Insights > Kamada

News List

Kamada Signs Supply Agreement with Israeli Health Authorities contractpharma
October 23, 2020
The Israeli health authorities have signed a supply agreement for the investigational Covid-19 plasma-derived Immunoglobulin (IgG), to be supplied by Kamada Ltd., a biopharmaceutical company which is partnered with Kedrion Biopharma in the development...
Kamada and Kedrion to develop immunoglobulin product for Covid-19 pharmaceutical-technology
April 30, 2020
Biopharmaceutical companies Kamada and Kedrion Biopharma have partnered to develop, manufacture and distribute a human plasma-derived polyclonal immunoglobulin (IgG) product for potential Covid-19 treatment.
Kamada, Takeda Discuss GLASSIA Manufacturing Transition contractpharma
August 09, 2019
In discussions to extend transition of Kamada’s Alpha-1 Antitrypsin Deficiency treatment to Takeda.
Kamada Receives Additional Shire Milestone contractpharma
June 13, 2017
Achieves sales milestone in GLASSIA supply and distribution agreement